Inkwell Capital LLC Invests $2.16 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Inkwell Capital LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,266 shares of the healthcare conglomerate's stock, valued at approximately $2,158,000. UnitedHealth Group comprises 2.3% of Inkwell Capital LLC's investment portfolio, making the stock its 21st largest position.

Several other institutional investors have also added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the 4th quarter valued at about $32,000. Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $40,000. Finally, DecisionPoint Financial LLC lifted its holdings in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after buying an additional 62 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.33% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Finally, StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Trading Up 1.6 %

NYSE UNH traded up $8.44 during trading hours on Monday, hitting $524.48. 5,236,968 shares of the company were exchanged, compared to its average volume of 4,272,845. The stock has a market cap of $479.75 billion, a PE ratio of 33.84, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average price of $508.81 and a 200 day moving average price of $543.92. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 earnings per share. The business's revenue was up 6.8% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group's payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.